Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.205 EUR | -1.12% | +1.85% | -15.84% |
Apr. 15 | Sanofi: progress in hematology trial | CF |
Apr. 15 | Innate Pharma: progress in hematology trial | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.84% | 191M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- IPH Stock
- News Innate Pharma
- Innate Pharma S A : Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target